Clinical Trial Results

Showing: All studies [change]
Condition: Obesity Location: Tustin, California 25 trials found
New Search
Filter
Trial Phase
Study Type
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
PHASE3INTERVENTIONAL Dothan, Alabama +4 more
RECRUITING
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
PHASE3INTERVENTIONAL Dothan, Alabama +4 more
RECRUITING
A Study of ABBV-295 Subcutaneous Injections to Assess Adverse Events and Pharmacokinetics in Adult Participants With Obesity
PHASE1INTERVENTIONAL Anaheim, California +1 more
RECRUITING
A Study to Learn How Different Forms of the Study Medicine Called Berobenatide is Taken up Into the Blood in Adults With Overweight or Obesity
PHASE1INTERVENTIONAL Anaheim, California
RECRUITING
A Study of LY4167586 in Participants With Obesity or Overweight With or Without Type 2 Diabetes
PHASE1INTERVENTIONAL Rogers, Arkansas +4 more
RECRUITING
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
PHASE3INTERVENTIONAL Daphne, Alabama +4 more
RECRUITING
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
A Study to Learn How Different Amounts of the Study Medicine Called PF-08642534 Are Tolerated and Act in the Body of People Who Have Obesity
PHASE1INTERVENTIONAL Lake Forest, California
RECRUITING
First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671
PHASE1, PHASE2INTERVENTIONAL Cypress, California +4 more
RECRUITING
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes
PHASE1, PHASE2INTERVENTIONAL Cypress, California
RECRUITING
Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)
PHASE1INTERVENTIONAL Cypress, California
RECRUITING
A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
PHASE2INTERVENTIONAL Cypress, California +2 more
RECRUITING
A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body Weight
PHASE1INTERVENTIONAL Cypress, California
RECRUITING
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
PHASE3INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
PHASE3INTERVENTIONAL Cullman, Alabama +4 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
PHASE3INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
PHASE3INTERVENTIONAL Lancaster, California +4 more
RECRUITING
Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)
PHASE1INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
PHASE2INTERVENTIONAL San Dimas, California +4 more
RECRUITING
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
PHASE2INTERVENTIONAL Huntsville, Alabama +4 more
RECRUITING
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type